alanylglutamine has been researched along with Bowel Diseases, Inflammatory in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chachar, B; Gao, Y; Hou, J; Hu, M; Li, M; Li, X; Xu, Q; Zhang, X | 1 |
| Chao, CJ; Chu, CC; Hou, YC; Pai, MH; Yeh, SL | 1 |
| Bischoff, SC; Borchert, K; Lochs, H; Manns, MP; Ockenga, J; Stüber, E | 1 |
1 trial(s) available for alanylglutamine and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease.
Topics: Acute Disease; Adult; Dietary Supplements; Dipeptides; Disease Progression; Female; Glutamine; Humans; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Lactulose; Male; Middle Aged; Nitrogen; Nutritional Status; Parenteral Nutrition, Total; Permeability; Sample Size; Time Factors; Xylose | 2005 |
2 other study(ies) available for alanylglutamine and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Dietary Bioactive Peptide Alanyl-Glutamine Attenuates Dextran Sodium Sulfate-Induced Colitis by Modulating Gut Microbiota.
Topics: Animals; Colitis; Dipeptides; Gastrointestinal Microbiome; Humans; Inflammatory Bowel Diseases; Male; Mice; Sulfates | 2021 |
Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Dipeptides; Disease Models, Animal; Down-Regulation; Haptoglobins; Inflammatory Bowel Diseases; Injections, Intraperitoneal; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Peroxidase; Severity of Illness Index; T-Lymphocytes, Helper-Inducer | 2012 |